Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.

Al Mosaid A, Sullivan DJ, Polacheck I, Shaheen FA, Soliman O, Al Hedaithy S, Al Thawad S, Kabadaya M, Coleman DC.

J Clin Microbiol. 2005 Aug;43(8):4026-36.

2.

Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.

Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC.

FEMS Yeast Res. 2004 Jan;4(4-5):369-76. Review.

3.

Differentiation of Candida dubliniensis from Candida albicans on Pal's agar.

Al Mosaid A, Sullivan DJ, Coleman DC.

J Clin Microbiol. 2003 Oct;41(10):4787-9.

4.

High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer.

Bagg J, Sweeney MP, Lewis MA, Jackson MS, Coleman D, Al MA, Baxter W, McEndrick S, McHugh S.

Palliat Med. 2003 Sep;17(6):477-81.

PMID:
14526879
5.

Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans.

Mosca CO, Moragues MD, Llovo J, Al Mosaid A, Coleman DC, Pontón J.

J Clin Microbiol. 2003 Mar;41(3):1259-62.

6.

Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar.

Al Mosaid A, Sullivan D, Salkin IF, Shanley D, Coleman DC.

J Clin Microbiol. 2001 Jan;39(1):323-7.

Supplemental Content

Loading ...
Support Center